Last-resort drug offered to brain cancer patients
Disease control
AVAILABLE
This program provides gallium maltolate (GaM) to adults aged 18 and older with glioblastoma that has returned or is not responding to standard treatments. The goal is to offer a possible treatment option when no others are available. Patients must be able to swallow capsules and …
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated Jun 17, 2026 00:46 UTC